American Academy of Pediatrics Recognizes Neurofeedback as being as effective as medication for ADHD

February 14th, 2013 - By admin in Information on ADD/ADHD, neuroAgility News, Neurofeedback News

Neurofeedback now a “Level 1 — Best Support” Intervention for Attention & Hyperactivity Behaviors

Prac­tice­Wise, the com­pany that main­tains the Amer­i­can Acad­emy of Pedi­atrics “Evidence-based Child and Ado­les­cent Psycho-social Inter­ven­tions” has just announced it will ele­vate biofeed­back to “Level 1 — Best Sup­port” as an inter­ven­tion for Atten­tion & Hyper­ac­tiv­ity Behav­iors in the next edi­tion. Work­ing Mem­ory Train­ing will stay at Level 2 — Good Sup­port (AAP chart may be viewed HERE). Stud­ies influ­enc­ing the deci­sion included:

  • Beau­re­gard, M., & Levesque, J. (2006). Func­tional mag­netic res­o­nance imag­ing inves­ti­ga­tion of the effects of neu­ro­feed­back train­ing on neural bases of selec­tive atten­tion and response inhi­bi­tion in chil­dren with attention-deficit/hyperactivity dis­or­der. Applied Psy­chol­ogy and Biofeed­back, 31, 3–20.
  • Gevensleben, H., Holl, B., Albrecht, B., Vogel, C., Schlamp, D., et al. (2009). Is neu­ro­feed­back an effi­ca­cious treat­ment for ADHD?: A ran­dom­ized con­trolled clin­i­cal trial. Jour­nal of Child Psy­chol­ogy and Psy­chi­a­try, 50, 780–789.
  • Levesque, J., Beau­re­gard, M., & Men­sour, B. (2006). Effect of neu­ro­feed­back train­ing on the neural sub­strates of selec­tive atten­tion in chil­dren with atten­tion deficit/hyperactivity dis­or­der: A func­tional mag­netic res­o­nance imag­ing study. Neu­ro­science Let­ters, 394, 216–221.
  • Omizo, M. M., & Michael, W. B. (1982). Biofeedback-induced relax­ation train­ing and impul­siv­ity, atten­tion to task, and locus of con­trol among hyper­ac­tive boys. Jour­nal of Learn­ing Dis­abil­i­ties, 15, 414–416.
  • Rivera, E., & Omizo, M. M. (1980). The effects of relax­ation and biofeed­back on atten­tion to task and impul­siv­ity among male hyper­ac­tive chil­dren. The Excep­tional Child, 27, 41–51.